Stay updated on Taldefgrobep Alfa in SMA Clinical Trial

Sign up to get notified when there's something new on the Taldefgrobep Alfa in SMA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Taldefgrobep Alfa in SMA Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations sections were updated to include a comprehensive list of trial sites across multiple states and Scotland, with Revision: v3.3.3. Previous site groupings were removed/restructured.
    Difference
    2%
    Check dated 2025-12-23T08:20:17.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. This appears to be a non-functional update related to versioning rather than study details or user-facing content.
    Difference
    0.0%
    Check dated 2025-11-24T17:08:43.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page removes a general government funding/operational status notice; core trial details, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T15:00:46.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The list of study locations has been expanded to include additional sites across multiple countries. This broadens participant access and informs how the trial is conducted.
    Difference
    0.3%
    Check dated 2025-11-03T01:28:51.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated medical term from Proximal spinal muscular atrophy to spinal muscular atrophy and bumped revision to v3.2.0; added a government operations status notice. Removed the more specific term and previous version label.
    Difference
    4%
    Check dated 2025-10-05T10:34:48.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Updated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.
    Difference
    0.4%
    Check dated 2025-09-28T03:23:23.000Z thumbnail image

Stay in the know with updates to Taldefgrobep Alfa in SMA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Taldefgrobep Alfa in SMA Clinical Trial page.